Literature DB >> 15870900

Interleukin-15 decreases lipid intestinal absorption.

Vanessa Almendro1, Neus Carbó, Sílvia Busquets, Joaquín López-Soriano, Maite Figueras, Elisabet Ametller, Josep M Argilés, Francisco J López-Soriano.   

Abstract

Administration of a single acute intravenous injection of interleukin-15 (IL-15) (100 microg/kg bw) to rats resulted in a significant decrease (22%) in triacylglycerol absorption, as measured by using [14C]-triolein load. The cytokine, however, did not influence the oxidation of the exogenously administered lipid or the tissue uptake of [14C]-triolein; this is in concordance with the lack of effects found in the measurement of the tissue lipoprotein lipase activity. Concerning the mechanism involved in the decreased intestinal absorption associated with IL-15 administration, the results presented clearly demonstrate that changes in gastric emptying and intestinal mobility are not involved, as the effect is specific for triacylglycerols. In conclusion, intestinal absorption may be an additional mechanism to take into consideration to explain the 'anti-fat' effect of this cytokine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870900

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

1.  Interleukin-15, IL-15 Receptor-Alpha, and Obesity: Concordance of Laboratory Animal and Human Genetic Studies.

Authors:  Lebris S Quinn; Barbara G Anderson
Journal:  J Obes       Date:  2011-03-29

2.  Interleukin-15 treatment induces weight loss independent of lymphocytes.

Authors:  Nicole G Barra; Marianne V Chew; Sarah Reid; Ali A Ashkar
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

3.  Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype.

Authors:  Yi He; Qijing Bo; Zhen Mao; Jian Yang; Min Liu; Haixia Wang; Abba J Kastin; Weihong Pan; Chuanyue Wang; Zuoli Sun
Journal:  Front Psychiatry       Date:  2022-03-09       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.